Introduction
Development of Novel Selective FPR1 Antagonist Against Neutrophil Related Inflammatory Disease
Features / strengths
Development of Novel Selective FPR1 Antagonist Against Neutrophil Related Inflammatory Disease
Specification in detail
pre-clinical stage
pre-clinical stage